BioCentury
ARTICLE | Management Tracks

Ovid promotes Alexander to COO

Plus: Tyra hires Warner as CMO and updates from Senisca, Closed Loop, NanoSyrinx and more

September 12, 2024 1:01 AM UTC

Ovid Therapeutics Inc. (NASDAQ:OVID) promoted Meg Alexander to president and COO from chief strategy officer and chief corporate affairs officer. Alexander joined Ovid as a VP in 2021. 

Tyra Biosciences Inc. (NASDAQ:TYRA), which is developing precision medicines targeting FGFR, hired Doug Warner as CMO. Warner was CMO of eFFECTOR Therapeutics Inc. (NASDAQ:EFTR)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article